Published in Gut on December 01, 1990
In vitro microbicidal activities of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trachomatis. Antimicrob Agents Chemother (2002) 0.97
Colonic fermentation of complex carbohydrates in patients with familial adenomatous polyposis. Gut (1993) 0.92
Inflammation does not decrease intraluminal pH in chronic inflammatory bowel disease. Dig Dis Sci (1999) 0.84
Lactate and pH in faeces from patients with colonic adenomas or cancer. Gut (1993) 0.82
Cell-specific effects of luminal acid, bicarbonate, cAMP, and carbachol on transporter trafficking in the intestine. Am J Physiol Gastrointest Liver Physiol (2012) 0.81
Colonic methanogenesis in vivo and in vitro and fecal pH after resection of colorectal cancer and in healthy intact colon. Int J Colorectal Dis (2011) 0.76
Extracellular acidosis stimulates NHE2 expression through activation of transcription factor Egr-1 in the intestinal epithelial cells. PLoS One (2013) 0.76
Gastrointestinal intraluminal pH. Gut (1991) 0.75
Functional Profile Evaluation of Lactobacillus fermentum TCUESC01: A New Potential Probiotic Strain Isolated during Cocoa Fermentation. Biomed Res Int (2017) 0.75
Bacteria and aetiology of cancer of large bowel. Lancet (1971) 5.16
Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut (1988) 3.14
Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device. Gut (1974) 2.89
Aetiology of adenoma--carcinoma sequence in large bowel. Lancet (1978) 2.52
High colonic pH promotes colorectal cancer. Lancet (1981) 2.16
Degradation of steroids by intestinal bacteria. II. Enzymes catalysing the oxidoreduction of the 3 alpha-, 7 alpha- and 12 alpha-hydroxyl groups in cholic acid, and the dehydroxylation of the 7-hydroxyl group. Biochim Biophys Acta (1970) 2.13
Parameters in 7-alpha-dehydroxylation of bile acids by anaerobic lactobacilli. Acta Pathol Microbiol Scand (1968) 1.50
The effect of wheat bran upon bile salt metabolism and upon the lipid composition of bile in gallstone patients. Am J Dig Dis (1976) 1.36
Faecal pH value and its modification by dietary means in South African black and white schoolchildren. S Afr Med J (1979) 1.33
Dietary fibre and regional large-bowel cancer mortality in Britain. Br J Cancer (1979) 1.24
Recent hypotheses for the origin of colon cancer. Cancer Res (1987) 1.08
Dietary fibre, fermentation and large bowel cancer. Cancer Surv (1987) 1.08
Dietary fibre consumption in Britain: new estimates and their relation to large bowel cancer mortality. Br J Cancer (1985) 1.04
Do colonic bacteria contribute to cholesterol gall-stone formation? Effects of lactulose on bile. Br Med J (Clin Res Ed) (1981) 1.03
The role of dietary fibre in the human colon. Can Med Assoc J (1980) 1.01
Experimental colorectal cancer: the relationship of diet and faecal bile acid concentration to tumour induction. Br J Surg (1986) 0.85
Delay in diagnosis and treatment of symptomatic colorectal cancer. Lancet (1979) 4.91
A classification of fistula-in-ano. Br J Surg (1976) 4.09
Controlled trial of faecal occult blood testing in the detection of colorectal cancer. Lancet (1983) 3.99
Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut (1988) 3.14
Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol (1991) 2.83
The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut (1999) 2.53
Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut (2002) 2.50
Surgical emergencies and manpower. Ann R Coll Surg Engl (1984) 2.48
Study of large bowel peristalsis. Gut (1968) 2.34
The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br J Surg (1985) 2.20
Ambulatory monitoring of oesophageal pH in reflux oesophagitis using a portable radiotelemetry system. Gut (1982) 2.19
Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery. Br J Surg (1994) 2.18
The results of 1115 patients with colorectal cancer treated over an 8-year period in a single hospital. Eur J Surg Oncol (1985) 2.03
Direct visualization of phosphorylase-phosphorylase kinase complexes by scanning tunneling and atomic force microscopy. Biophys J (1990) 1.97
Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut (1992) 1.96
A study of the association between gastro-oesophageal reflux and palatal dental erosion. Br Dent J (1996) 1.77
Radioimmunodetection of human colorectal cancers by an anti-tumour monoclonal antibody. Lancet (1982) 1.71
Ki-ras mutations in adenomas: a characteristic of cancer-bearing colorectal mucosa. J Pathol (1996) 1.70
Cost-effective screening strategies for colorectal cancer. J Public Health Med (1992) 1.67
Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut (2011) 1.67
Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs. Gut (2001) 1.59
Clinical and economic consequences of wound sepsis after appendicectomy and their modification by metronidazole or povidone iodine. Lancet (1981) 1.57
Physical factors in the stimulation of colonic peristalsis. Gut (1970) 1.57
Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer. Br J Cancer (2001) 1.56
Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer. Ann Oncol (1995) 1.53
Factors affecting compliance with screening for colorectal cancer. Community Med (1984) 1.52
Faecal occult blood screening for colorectal cancer: is it cost-effective? Health Econ (1998) 1.51
Diabetic impotence: studies of nocturnal erection during REM sleep. Br Med J (1979) 1.50
Screening for colorectal cancer with an immunological faecal occult blood test: 2-year follow-up. Br J Surg (1996) 1.49
Screening for symptomless colorectal cancer by testing for occult blood in general practice. Lancet (1980) 1.48
Clinical and radiographic features of simple and hydatid cysts of the liver. Br J Surg (1986) 1.47
A frequency-duration index (FDI) for the evaluation of ambulatory recordings of gastro-oesophageal reflux. Br J Surg (1984) 1.45
Bile reflux in columnar-lined Barrett's oesophagus. Ann R Coll Surg Engl (1993) 1.44
Screening and the costs of treating colorectal cancer. Br J Cancer (1993) 1.44
Acute non-tuberculous psoas abscess. Report of 10 cases and review of the literature. Br J Surg (1970) 1.42
Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial. Cancer (1986) 1.40
Flexible fiberoptic sigmoidoscopy and double-contrast barium-enema examination in the identification of adenomas and carcinoma of the colon. Dis Colon Rectum (1983) 1.39
Predeposit autologous blood transfusion in patients with colorectal cancer: a feasibility study. Br J Surg (1992) 1.39
Early diagnosis of colorectal cancer: a review. J R Soc Med (1984) 1.37
Subcuticular suturing after appendicectomy. Lancet (1977) 1.32
Attractive forces between uncharged hydrophobic surfaces: direct measurements in aqueous solution. Science (1985) 1.31
Scanning tunnelling microscopy of Z-DNA. Nature (1989) 1.31
Interval cancers in a randomized controlled trial of screening for colorectal cancer using a faecal occult blood test. Int J Epidemiol (1999) 1.29
An evaluation of flexible fibreoptic sigmoidoscopy. Br Med J (Clin Res Ed) (1981) 1.28
Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res (1995) 1.27
The action of sennosides and related compounds on human colon and rectum. Gut (1970) 1.22
Comparison of rigid and flexible fibreoptic sigmoidoscopy with double contrast barium enemas. Br J Surg (1982) 1.21
Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening. Br J Surg (1997) 1.21
Bleeding patterns in colorectal cancer: the effect of aspirin and the implications for faecal occult blood testing. Br J Surg (1982) 1.20
Assessment of proliferation of squamous, Barrett's and gastric mucosa in patients with columnar lined Barrett's oesophagus. Gut (1992) 1.20
Accuracy of occult blood tests over a six-day period. Clin Oncol (1983) 1.19
Colorectal screening by a self-completion questionnaire. Gut (1984) 1.19
A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer. Br J Cancer (1985) 1.19
Colorectal cancer, screening and survival: the influence of socio-economic deprivation. Public Health (2003) 1.18
Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidine. Gut (1993) 1.16
Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer. Cancer Res (1996) 1.15
A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner workload. J Epidemiol Community Health (1988) 1.15
Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7. Cancer Res (1994) 1.15
Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody. Cancer Res (1991) 1.14
Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody. Int J Cancer (1994) 1.13
Ambulatory esophageal pH monitoring in children as an indicator for surgery. J Pediatr Surg (1986) 1.13
A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol (2000) 1.13
Role of upper gastrointestinal investigations in a screening study for colorectal neoplasia. Gut (1990) 1.11
Twenty-four hour ambulatory oesophageal pH monitoring: an update. Br J Surg (1987) 1.10
Reflux versus dysphagia: an objective evaluation of the Angelchik prosthesis. Br J Surg (1985) 1.09
Dose beta-blockade affect surgical performance? a double blind trial of oxprenolol. Br J Surg (1980) 1.08
Twenty four hour oesophageal acidity in achalasia before and after pneumatic dilatation. Gut (1987) 1.07
Long-range attractive force between hydrophobic surfaces observed by atomic force microscopy. Science (1993) 1.07
Role of dietary restriction in Haemoccult screening for colorectal cancer. Br J Surg (1989) 1.07
Accuracy of identification of early gastric cancer. Br J Surg (1987) 1.06
Association of antigen expression and DNA ploidy in human colorectal tumors. Cancer Res (1986) 1.06
Immunohistochemical localization of Y hapten and the structurally related H type-2 blood-group antigen on large-bowel tumours and normal adult tissues. Int J Cancer (1984) 1.04
Imaging of pancreatic and colorectal cancer using antibody fragments: a preliminary evaluation. Eur J Surg Oncol (1988) 1.04
Evaluation of the plain abdominal X-ray in the acute abdomen. J R Soc Med (1985) 1.04
Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests. Br J Surg (1994) 1.03
Endoscopic review of patients who have had gastric surgery. Br Med J (Clin Res Ed) (1983) 1.03
Detection of colorectal liver metastases using intraoperative ultrasonography. Br J Surg (1991) 1.02
Viewing molecules with scanning tunneling microscopy and atomic force microscopy. FASEB J (1990) 1.01
Localisation of human osteosarcoma by antitumour monoclonal antibody. J Bone Joint Surg Br (1983) 1.00
Antigenicity of newly established colorectal carcinoma cell lines. Br J Cancer (1986) 1.00
Haemoccult screening for colorectal cancer: the effect of dietary restriction on compliance. Eur J Surg Oncol (1994) 1.00
Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression. Br J Cancer (1987) 1.00
Psychiatric morbidity and screening for colorectal cancer. J Med Screen (2002) 1.00
Can albendazole reduce the risk of implantation of spilled protoscoleces? An animal study. Trans R Soc Trop Med Hyg (1986) 0.98
The descending perineum syndrome. Practitioner (1969) 0.98
Colorectal adenomas and energy intake, body size and physical activity: a case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Br J Cancer (1993) 0.98
Screening of average-risk individuals for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ (1990) 0.98
Effects of neostigmine and atropine on motor activity of ileum, colon, and rectum of anaesthetized subjects. Br Med J (1970) 0.97
The localization of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumours. Br J Surg (1984) 0.97
The relationship between gastro-oesophageal reflux disease and dental erosion. J Oral Rehabil (1996) 0.97
Hepatic perfusion index in the diagnosis of overt metastatic colorectal cancer. Nucl Med Commun (1990) 0.97